Leukocyte transmembrane potential in bipolar illness

Journal of Affective Disorders

Volumn 41, Issue 1, 1996, Pages 33-37

  El Mallakh, Rif S ^a   Li, Rena ^a   Worth, Christopher A ^a   Peiper, Stephen C ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Bipolar illness; Flow cytometry; Leukocyte; Transmembrane potential

Indexed keywords

AMITRIPTYLINE PLUS PERPHENAZINE; CARBAMAZEPINE; CLONAZEPAM; DIPHENHYDRAMINE; FLUPHENAZINE; HALOPERIDOL; LITHIUM; NIFEDIPINE; PAROXETINE; SERTRALINE; VERAPAMIL;

ADULT; ARTICLE; BIPOLAR DEPRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; LEUKOCYTE; MALE; MANIA; MEMBRANE POTENTIAL; PRIORITY JOURNAL;

EID: 0030569262     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-0327(96)00063-8     Document Type: Article

References (21)

1. Abdulla, Y.H. and Hamadah, K. (1970) 3′,5′-Cyclic adenosine monophosphate in depression and mania. Lancet i, 378-381.
2. Akagawa, K., Wakanabe, M. and Tsukada, Y. (1980) Activity of erythrocyte Na,K-ATPase in manic patients. J. Neurochem. 35, 258-260.
3. Arana, G.W., Baldessarini, R.J. and Omsteen, M. (1985) The dexamethasone suppression test for diagnosis anf prognosis in psychiatry. Arch. Gen. Psychiatry 42, 1193-1204
4. Bigelow, L.B. and Berthot, B.D. (1989) The Psychiatric Symptom Assessment Scale (PSAS). Psychopharmacol. Bull. 25, 168-179.
5. Christo, P.J. and El-Mallakh, R.S. (1993) Possible role of endogenous ouabain-like compounds in the pathophysiology of bipolar illness. Med. Hypotheses 41, 378-383.
6. Coppen, A., Shaw, D.M., Malleson, A. and Costain, R. (1966) Mineral metabolism in mania. Br. Med. J. 1, 71-75.
7. Dick, D.A.T., Naylor, G.J. and Dick, E. G. (1982) Plasma vanadium concentration in manic depressive illness. Psychol. Med. 12, 533-537.
8. Dubovsky, S.L. and Franks, R.D. (1983) Intracellular calcium ions in affective disorders: A review and an hypothesis. Biol. Psychiatry 18, 781-797.
9. Dubovsky, S.L., Murphy, J., Thomas, M. and Rademacher, J. (1992) Abnormal intracellular calcium ion concentration in platelets and lymphocytes of bipolar patients. Am. J. Psychiatry 149, 118-120.
10. El-Mallakh, R.S. (1994) Preventing bipolar relapse while avoiding lithium toxicity: The role of the lithium ratio and intraerythrocyte lithium concentration determination. Lithium 5, 17-22.
11. +-ATPase the link between phosphoinositide metabolism and bipolar disorder? J. Neuropsychiatry Clin. Neurosci. 4, 361-368
12. El-Mallakh, R.S., Barrett, J.L. and Wyatt, R.J. (1993) The Na,K-ATPase hypothesis for bipolar disorder. Implications of normal development. J. Child Adolesc. Psychopharmacol. 3, 37-52.
13. El-Mallakh, R.S. and Wyatt, R.J. (1995) The Na,K-ATPase hypothesis for bipolar illness. Biol. Psychiatry 37, 235-244.
14. Hokin-Neaverson, M. and Jefferson, J.W. (1989) Deficient erythrocyte Na,K-ATPase in different affective states in bipolar affective disorder and normalization by lithium therapy. Neuropsychobiology 22, 18-25.
15. Kessel, D., Beck, W.T., Kukuruga, D. and Schulz, V. (1991) Characterization of multidrug resistance by fluorescent dyes. Cancer Res. 51, 4665-4670.
16. Meltzer, H.L. and Kassir, S. (1983) Abnormal calmodium-activated CaATPase in manic-depressive subjects. J. Psychiatric Res. 17, 29-35.
17. Meltzer, H.L., Kassir, S., Goodnick, P.J. et al. (1988) Calmodium-activated calcium ATPase in affective disorders. Neuropsychobiology 20, 169-173.
18. Naylor, G.J., McNamee, H.B. and Moody, J.P. (1971) Changes in erythrocyte sodium and potassium on recovery from depressive illness. Br. J. Psychiatry 118, 219-223.
19. Naylor, G.J., Smith, A.H.W., Bryce-Smith, D. and Ward, N.I. (1980) Tissue vanadium levels in manic depressive psychosis. Psychol. Med. 14, 767-772.
20. Reddy, P.L., Khanna, S., Subhash, M.N. Channabasavanna, S.M. and Rao, B.S.S.R. (1992) Erythrocyte membrane sodium-potassium adenosine triphosphatase activity in affective disorders. J. Neural Tranm. 89, 209-218.
21. Shaw, D.M. (1966) Mineral metabolism, mania, and melancholia. Br. Med. J. 2, 262-267.